A Study to Evaluate Awareness and Knowledge of the Fibristal Additional Risk Minimization Measures Among Healthcare Professionals in Canada
NCT04567589 · Status: WITHDRAWN · Type: OBSERVATIONAL
Last updated 2020-10-22
Summary
This is a non-interventional, cross-sectional survey study to evaluate the effectiveness of the Additional Risk Minimization Measures for Fibristal among Healthcare Professionals (HCPs).
Conditions
- Uterine Fibroids
Sponsors & Collaborators
-
Allergan
lead INDUSTRY
Principal Investigators
-
Ahunna Ukah · Allergan
Eligibility
- Sex
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-09-30
- Primary Completion
- 2021-02-28
- Completion
- 2021-02-28
Countries
- United States
Study Locations
More Related Trials
-
Cryoablation Versus Radiofrequency Ablation for Small Renal Masses
NCT00922948 ·Status: WITHDRAWN ·Phase: PHASE2
-
First Clinical Study of Erbium - Yttrium Aluminium Garnet (YAG) Laser Vaporization of Cutaneous Neurofibromas
NCT00921037 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Microwave Ablation for Leiomyoma
NCT04240262 ·Status: UNKNOWN
-
China Clinical Trial for Therapeutic MR-HIFU Ablation of Uterine Fibroids
NCT01588899 ·Status: COMPLETED ·Phase: NA
-
Assessing the Efficacy of Repeat, Monthly Treatments of Deoxycholate for NF1 Associated Cutaneous Neurofibromas (cNFs)
NCT06300502 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE1
-
Observing People With Desmoid-Type Fibromatosis
NCT04281381 ·Status: RECRUITING
-
Surgical Resection of Latent Brain Tumors Prior to Recurrence
NCT04810871 ·Status: SUSPENDED ·Phase: NA
-
The Value of Advanced MR Imaging in Gynecological Tumors and Benign Uterine Fibroids
NCT03993210 ·Status: TERMINATED ·Phase: NA
-
Efficacy and Safety of REC-2282 in Patients With Progressive Neurofibromatosis Type 2 (NF2) Mutated Meningiomas
NCT05130866 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Establishment of a Decision Aid Tool for Asymptomatic Small Leiomyoma and Analysis of Influencing Factors for Clinical Decision-making Using HIFU
NCT05500118 ·Status: RECRUITING
-
MR Guided Focused Ultrasound Surgery in the Treatment of Breast Fibroadenomas
NCT00147108 ·Status: TERMINATED ·Phase: PHASE3
-
Open Label Immunotherapy of Myoma
NCT03550703 ·Status: UNKNOWN ·Phase: PHASE2
-
Feasibility of Ultra-sound Guided Radiofrequency Ablation in the Management of Head and Neck Neoplasia.
NCT00381225 ·Status: WITHDRAWN ·Phase: NA
-
MicroRNAs in Patients With Neurofibromatosis Type 1
NCT01595139 ·Status: COMPLETED
-
Study of Volume Reduction of Uterine Fibroids After Embolization or Microwave Treatment
NCT02942537 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
DNA Analysis of Tumor Tissue Samples From Patients With Diffuse Brain Stem Glioma
NCT00899834 ·Status: COMPLETED
-
A Long-term Study of NPC-12G Gel in Neurofibromatosis Type I
NCT04461886 ·Status: TERMINATED ·Phase: PHASE3
-
An Implant for Hearing Loss Due to Removal of Neurofibromatosis 2 Tumors
NCT00030043 ·Status: COMPLETED ·Phase: PHASE1
-
Microscopic Fluorescence-guided Vestibular Schwannoma Resection Using Fluorescein Sodium and YELLOW 560
NCT04351373 ·Status: COMPLETED ·Phase: PHASE2
-
Subtotal Resection of Large Acoustic Neuromas With Possible Stereotactic Radiation Therapy
NCT01129687 ·Status: COMPLETED
-
Transformation of Plexiform Neurofibromas to Malignant Peripheral Nerve Sheath Tumors in Neurofibromatosis Type 1
NCT02211768 ·Status: COMPLETED ·Phase: PHASE1
-
Laboratory Study of Early Tumor Markers in the Peripheral Blood of Glioblastoma Multiforme Patients
NCT01135875 ·Status: COMPLETED
-
Study of Stored Tumor Samples in Young Patients With Brain Tumors
NCT00897286 ·Status: TERMINATED
-
Treatment of Breast Fibroadenoma With High Intensity Focused Ultrasound
NCT02078011 ·Status: COMPLETED ·Phase: NA
-
Analysis of Circulating DNA in Blood Samples of Glioma-affected Patients
NCT05964153 ·Status: UNKNOWN ·Phase: NA